期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | DIABETES LetPub Score 9.0
50 ratings
Rate
Reputation 9.9 Influence 8.3 Speed 9.3 | ||||||||||||||||||||
期刊簡稱 | DIABETES | ||||||||||||||||||||
ISSN | 0012-1797 | ||||||||||||||||||||
E-ISSN | 1939-327X | ||||||||||||||||||||
h-index | 304 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 1.60%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://diabetes.diabetesjournals.org/ | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/diabetes | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | American Diabetes Association Inc. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1952 | ||||||||||||||||||||
每年文章數 | 152每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 3.07% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0012-1797%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 1.0 month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 37.5% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[DIABETES] 的評論 | 撰寫評論 |
作者: 截手爱敏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-03 18:37:35 評論於 What was your state of mind at that time?(0) 讚! | 截手爱敏 |
作者: 玄虚水秋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-22 20:29:59 評論於 How long does it take from submission to acceptance?(0) 讚! | 玄虚水秋 |
作者: Olive Kitto 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-20 18:30:38 評論於 Brother, does "with associated editor" mean it has been sent out for review? It's so slow, it's been almost a month already, and it's still with associated editor(0) 讚! | Olive Kitto |
作者: 努力啊大元彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-21 16:28:38 評論於 When do you need to submit the original data for the magazine, and what are the specific requirements?(0) 讚! | 努力啊大元彤 |
作者: 西行寺运诚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-02 12:33:00 評論於 Submitted in November 2022, it has been 6 months and still inviting reviewers. 5 months in, reminders were sent with no response using a domestic email, but received a reply on the same day using an international email. Suggestions for reviewers were made for the editorial committee to review, but it has been a month and still no response. There is arrogance everywhere, so it's better to be cautious before submitting(0) 讚! | 西行寺运诚 |
作者: 西行寺运诚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-02 10:53:19 評論於 Review Speed: 24.0 | Submission Success Rate: 5.0 Experience Sharing: I have been submitting for 6 months since November 21, still inviting reviewers. At 5 months, I used my domestic unit email to urge for submission, with no response, changed to a foreign email, and got a response the same day, saying it will be processed as soon as possible. It has been a month and still in this state, showing arrogance everywhere. Be cautious when submitting(0) 讚! | 西行寺运诚 |
作者: 代晴mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-16 23:46:16 評論於 Submitted on 2.7, rejected on 2.16. The rejection letter is a template and doesn't provide any feedback(0) 讚! | 代晴mm |
作者: 代晴mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-15 09:42:43 評論於 Received, thank you senior(0) 讚! | 代晴mm |
作者: 无相伊果 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-12 16:30:43 評論於 Rejecting a submission directly seems to be within 3 days. If it reaches the editorial review, it means passing the first round. Then it will be sent for further review(0) 讚! | 无相伊果 |
作者: 代晴mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-08 08:38:32 評論於 The submission was made on February 7th, and on February 10th, it is still at the stage of being reviewed by the Editorial Committee. However, I am in a hurry to graduate now. I would like to ask experienced seniors, how long does it take for the editor to reject a submission directly?(0) 讚! | 代晴mm |
作者: 无相伊果 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-06 17:58:18 評論於 Hello, I am also in the stage of inviting reviewers. May I ask how long you waited afterwards?(0) 讚! | 无相伊果 |
作者: 无相伊果 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-06 16:04:26 評論於 I'm the same. How did things turn out later?(0) 讚! | 无相伊果 |
作者: Toby Nahum 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-17 16:12:00 評論於 Is there a high chance of diabetes being accepted after submission?(0) 讚! | Toby Nahum |
作者: 小困顿吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-16 18:06:48 評論於 Non-OA is also a one-page paper for $160(0) 讚! | 小困顿吖 |
作者: Edison Partridge 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-24 15:49:03 評論於 Three months is too slow. What happened later?(0) 讚! | Edison Partridge |
作者: Edison Partridge 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-26 18:36:42 評論於 It has been two weeks and I am still awaiting admin processing. Can I send an email to follow up? It has not reached the editor yet, who should I contact?(0) 讚! | Edison Partridge |
作者: Edison Partridge 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-20 23:59:44 評論於 It has been a week since submission and the status has been Awaiting Admin Processing. Have the submission not reached the hands of the editor yet? How long will it take to receive a response?(0) 讚! | Edison Partridge |
作者: 烈焰赤奋若 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-02 08:40:13 評論於 Thank you(0) 讚! | 烈焰赤奋若 |
作者: Lynn Gibbon 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-09 22:50:43 評論於 You can apply for exemption from OA(0) 讚! | Lynn Gibbon |
作者: Lynn Gibbon 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-09 18:53:17 評論於 Editorial speed: 1.0 | Submission acceptance rate: 50.0 Focus on research area: diabetes and obesity Experience sharing: Under review in just one week, feedback returned within a month. Currently in the process of revising manuscript(0) 讚! | Lynn Gibbon |
作者: Lynn Gibbon 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-09 15:04:23 評論於 It shouldn't happen(0) 讚! | Lynn Gibbon |
作者: mei110 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-08 09:51:42 評論於 2022-2-2 Submission 2022-2-10 Inviting reviewers 2022-2-11 Under review 2022-3-7 Major revision Given three months of time, currently conducting experiments to address the comments from the reviewers. The reviewers' opinions are quite professional. Will share further updates in the future. Hoping for smooth progress ahead!(0) 讚! | mei110 |
作者: 烈焰赤奋若 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-13 17:17:55 評論於 Emphasis on research direction: Diabetic peripheral neuropathy Sharing of experience: Never submitted before, planning to give it a try. Will a manuscript be rejected for lack of language editing?(0) 讚! | 烈焰赤奋若 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:53:21 評論於 Most Chinese names are spelled out in full pinyin(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:21:57 評論於 The corresponding author of a SCI journal article does not necessarily have to be only one person, and there is no fixed standard for how many there should be. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if the article lists multiple corresponding authors, the first corresponding author listed will automatically be chosen. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements— the number of corresponding authors listed in the article must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiment and writing of the article, and is the person listed first in the author column. However, in cases of collaboration between multiple authors, it is common to have co-first authors. There is no clear regulation on the number of co-first authors, and this is largely dependent on factors such as the workload and length of the paper, as well as the regulations of the publishing journal and the recognition of the affiliated units. Generally speaking, it is most common for an SCI paper to have 2-4 first authors(0) 讚! | 维尔娜菲茨杰拉德 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us